48 results
20-F
2021 FY
EX-4.11
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
for Severance Benefits attached hereto.
During your employment, you will be eligible to participate in the standard benefits plans offered to similarly situated … termination.
A full description of these benefits is available for your review. The Company may change compensation and benefits from time to time in its
20-F
2021 FY
EX-4.10
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
to Employment Offer Letter for Severance Benefits attached hereto.
During your employment, you will be eligible to participate in the standard benefits plans … nor paid out upon termination.
A full description of these benefits is available for your review. The Company may change compensation and benefits
F-1
EX-10.11
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
not interfere with his duties to the Company, as determined in good faith by the Board.
3. Compensation and Benefits. The Company shall pay … or provide, as the case may be, to Executive the compensation and other benefits and rights set forth in this Section 3.
(a) Base Salary. The Company shall
F-1
EX-10.12
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
Clause
Page
DEFINITIONS
DATE OF COMMENCEMENT AND DURATION
APPOINTMENT AND DUTIES
MOBILITY
REMUNERATION AND OTHER BENEFITS
CONFIDENTIAL INFORMATION …
RECEIPT OF PAYMENTS AND BENEFITS FROM THIRD PARTIES
EARLY TERMINATION OF APPOINTMENT
RESTRICTIVE COVENANTS
WARRANTY
MISCELLANEOUS
GOVERNING LAW
F-1
EX-10.14
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
to Employment Offer Letter for Severance Benefits attached hereto or otherwise, except as may be expressly required according to UK law. After travel … will not have earned the bonus and will not receive any portion of it, except as set forth in the Addendum to Employment Offer Letter for Severance Benefits
F-1
EX-10.15
sc1y3
26 Feb 21
Registration statement (foreign)
4:56pm
F-1/A
EX-10.4
2quna
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
6-K
EX-99.1
pvsbu4tu9oq0 a7
5 Jan 22
Current report (foreign)
5:24pm
F-1/A
EX-10.2
fafs 7g14
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
vlddxc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
7yuevo
17 Mar 21
Registration statement (foreign) (amended)
6:38am
6-K
EX-99.1
xqagphac1pqy qija
10 Jun 22
Current report (foreign)
6:05am
20-F
gj8tpml 0k6
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
65600d7qffb
31 Mar 22
Annual report (foreign)
4:33pm
S-8
EX-4.3
fjdk4
19 Mar 21
Registration of securities for employees
5:13pm
F-1/A
EX-99.1
mf8sl3ryiql0ew1h5
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-4.2
46ffu 484
12 Mar 21
Registration statement (foreign) (amended)
5:02pm